Universal Health Realty Income Trust (UHT)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $540.14M
Last updated: Nov 17, 2026 at 11:05 AM ET
Universal Health Realty Income Trust (UHT) Financials: Revenue, Profit and Cash Flow
Universal Health Realty Income Trust reported revenue of $99.19M for the fiscal year ended Dec 31, 2025, up 0.2% from the year before. That year, net income was $17.61M with a net margin of 17.8%, operating cash flow was $49.09M and free cash flow was $49.09M. The quarter ended Sep 30, 2026 had revenue of $25.35M and net income of $4.93M.
Revenue and Margins
The operating margin was 35.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $50.78M, a compound annual rate of 7.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $99.19M | +0.2% | 94.4% | 35.0% | 17.8% |
| Dec 2024 | $99.01M | +3.8% | 94.5% | 37.2% | 19.4% |
| Dec 2023 | $95.34M | +5.2% | 94.7% | 32.9% | 16.2% |
| Dec 2022 | $90.63M | +7.6% | 94.4% | 33.8% | 23.3% |
| Dec 2021 | $84.19M | +7.9% | 94.8% | 34.3% | 129.7% |
| Dec 2020 | $78.01M | -49.5% | 94.7% | 33.3% | 24.9% |
| Dec 2019 | $154.33M | +88.4% | 47.4% | 16.7% | 12.3% |
| Dec 2018 | $81.91M | +13.2% | 88.4% | 32.6% | 29.5% |
| Dec 2017 | $72.35M | +42.5% | 95.1% | 33.2% | 63.1% |
| Dec 2016 | $50.78M | N/A | 125.7% | 43.5% | 33.9% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 8.4% from the year before. In the quarter ended Sep 2026, net income rose 22.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99.19M | $99.01M | $95.34M | $90.63M | $84.19M | $78.01M | $154.33M | $81.91M | $72.35M | $50.78M |
| Cost of revenue | $5.59M | $5.48M | $5.32M | $5.10M | $4.41M | $4.14M | $3.97M | $3.81M | $3.58M | $3.26M |
| Gross profit | $93.59M | $93.53M | $90.25M | $85.53M | $79.78M | $73.87M | $73.19M | $72.40M | $68.77M | $63.82M |
| Operating income | $34.76M | $36.80M | $31.35M | $30.67M | $28.86M | $26.00M | $25.75M | $26.70M | $24.04M | $22.11M |
| Net income | $17.61M | $19.23M | $15.40M | $21.10M | $109.17M | $19.45M | $18.96M | $24.20M | $45.62M | $17.21M |
| EBITDA | $64.22M | $64.81M | $59.40M | $57.74M | $56.90M | $52.11M | $129.17M | $57.76M | $48.99M | $25.30M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25.35M | $24.99M | $24.53M | $24.47M | $25.30M | $24.87M | $24.55M | $24.64M | $24.49M | $24.73M | $25.14M | $24.09M |
| Gross profit | N/A | N/A | $17.31M | $69.84M | $23.89M | $23.48M | $23.18M | $23.25M | $23.11M | $23.36M | $23.80M | $22.95M |
| Operating income | N/A | N/A | $8.96M | $27.69M | $8.39M | $8.84M | $9.03M | $9.26M | $8.49M | $9.58M | $9.46M | $8.15M |
| Net income | $4.93M | $5.91M | $5.02M | $4.32M | $4.02M | $4.49M | $4.78M | $4.66M | $4.00M | $5.28M | $5.30M | $3.59M |
Balance Sheet
As of Dec 2025, total debt of $374.63M exceeded cash and equivalents by $367.95M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $564.91M | $580.86M | $596.37M | $607.54M | $598.42M | $494.01M | $488.79M | $483.76M | $490.01M | $524.75M |
| Current assets | $20.02M | $105.00M | $105.84M | $105.05M | $116.69M | $16.45M | $16.71M | $15.24M | $12.49M | $11.54M |
| Cash and equivalents | $6.69M | $7.10M | $8.21M | $7.61M | $22.50M | $5.74M | $6.11M | $5.04M | $3.39M | $3.93M |
| Total liabilities | $412.52M | $401.32M | $395.44M | $378.44M | $363.09M | $335.00M | $307.06M | $285.15M | $279.45M | $333.47M |
| Short-term debt | $356.20M | $348.90M | $326.60M | $298.10M | $271.90M | $236.20M | $212.95M | $196.40M | $181.05M | $201.50M |
| Long-term debt | $18.43M | $19.35M | $32.86M | $44.73M | $56.87M | $58.90M | $60.74M | $64.88M | $75.36M | $114.22M |
| Shareholder equity | $152.38M | $179.54M | $200.93M | $229.10M | $235.33M | $159.00M | $181.73M | $198.61M | $210.56M | $191.28M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $573.01M | $567.12M | $563.76M | $564.91M | $568.04M | $573.02M | $573.48M | $580.86M | $584.33M | $586.55M | $596.19M | $596.37M |
| Total liabilities | $433.51M | $423.21M | $415.96M | $412.52M | $409.46M | $407.86M | $401.32M | $401.32M | $402.69M | $395.85M | $399.73M | $395.44M |
| Cash and equivalents | $6.47M | $6.82M | $7.06M | $6.69M | $6.92M | $6.55M | $6.97M | $7.10M | $6.37M | $5.58M | $7.70M | $8.21M |
| Shareholder equity | $139.50M | $143.91M | $147.80M | $152.38M | $158.57M | $165.15M | $172.17M | $179.54M | $181.64M | $190.70M | $196.46M | $200.93M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 100.0% of operating cash flow. Dividends came to 83.6% of it, with no share repurchases.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $49.09M | $46.91M | $42.94M | $46.80M | $47.73M | $44.21M | $42.65M | $42.93M | $46.01M | $40.73M |
| Capital expenditures | $0 | $0 | $7.62M | $13.62M | $12.99M | $2.27M | $5.11M | $4.05M | $9.04M | $60.39M |
| Free cash flow | $49.09M | $46.91M | $35.32M | $33.19M | $34.74M | $41.94M | $37.55M | $38.88M | $36.97M | -$19.66M |
| Dividends paid | $41.03M | $40.39M | $39.77M | $39.18M | $38.53M | $37.97M | $37.41M | $36.83M | $36.05M | $35.17M |
| Share repurchases | $0 | $0 | $0 | $0 | $0 | $235.00K | $221.00K | $0 | N/A | N/A |
| Investing cash flow | -$14.96M | -$13.88M | -$19.11M | -$36.67M | -$24.43M | -$27.21M | -$16.47M | -$7.96M | $39.46M | -$74.83M |
| Financing cash flow | -$34.55M | -$34.15M | -$23.23M | -$25.02M | -$6.54M | -$17.37M | -$25.11M | -$33.32M | -$86.01M | $34.14M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $9.12M | $12.40M | $11.95M | $13.60M | $10.20M | $13.69M | $11.61M | $13.15M | $9.89M | $12.13M | $11.74M | $10.46M |
| Capital expenditures | N/A | N/A | $0 | $8.84M | $5.61M | $3.71M | $0 | $9.07M | $6.04M | $0 | $0 | $22.00K |
| Free cash flow | N/A | N/A | $11.95M | $4.76M | $4.59M | $9.97M | $11.61M | $4.08M | $3.86M | $12.13M | $11.74M | $10.43M |
Frequently Asked Questions About UHT
What is Universal Health Realty Income Trust's annual revenue?
Universal Health Realty Income Trust reported revenue of $99.19M for the fiscal year ended Dec 31, 2025.
How fast is Universal Health Realty Income Trust's revenue growing?
Revenue was up 0.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 3.1%.
Is Universal Health Realty Income Trust profitable?
Yes. Universal Health Realty Income Trust reported net income of $17.61M for the fiscal year ended Dec 31, 2025, with a net margin of 17.8%.
How much free cash flow does UHT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $49.09M minus capital expenditures of $0 produced free cash flow of $49.09M.
How much debt does Universal Health Realty Income Trust have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $18.43M, short-term debt of $356.20M and cash and equivalents of $6.69M.
UHT pages: Overview, Dividends, Earnings, Financials, Valuation, Competitors